Lyora Therapeutics, Inc.

Biotechnology company · Belmont, Massachusetts, United States

Lyora Therapeutics, Inc. is a biotechnology company headquartered in Belmont, Massachusetts, United States. Its earliest recorded incorporation is in 2024. It has reported private securities offerings to the US SEC, most recently $525,000 sold in a notice filed in 2025.

Profile compiled from public records. Is this your company? Request a correction or update

Lyora Therapeutics at a glance

Typebiotechnology company
HeadquartersBelmont, Massachusetts, United States
Earliest incorporation on record2024
SEC CIK2058969

What does Lyora Therapeutics do?

Private fundraising reported to the SEC

1 Form D notice; the most recent reported $525,000 sold (2025).

Frequently asked questions about Lyora Therapeutics

Where is Lyora Therapeutics headquartered?

Lyora Therapeutics, Inc. is headquartered in Belmont, Massachusetts, United States.

What does Lyora Therapeutics do?

Lyora Therapeutics, Inc. is a biotechnology company.

When was Lyora Therapeutics founded?

The earliest incorporation on record for Lyora Therapeutics, Inc. is in 2024, according to public company registers.

Similar companies

Need a CRO or CDMO for your next study?

Compare transparent quotes from research and manufacturing partners, then contract once. Free for buyers.

Compare quotes

Last updated 2026-09-23. Data licences